…therapy medicinal products (ATMP) being developed, with incredible potential for treating cancer, says Panagiotis Parsonidis, a molecular biologist and lead researcher at RGCC. DDW speaks to him about VAXO-Q-RE developments,…
…oncology and other therapeutic areas. Synthetic, medicinal, and computational chemistry capabilities along with in house available diversity and focused libraries Small molecule and biologics targeted screening for GPCRs, kinases, ion…
…of Biomedical Sciences, and virologists from the School of Chemistry and Molecular Biosciences. “We studied the effect of the virus on the brain’s immune cells, ‘microglia’ which are the key…
A new system utilising artificial intelligence (AI), ‘building-block’ chemistry and a molecule-making machine could speed up innovation and drug discovery, as well as make complex chemistry automated and accessible. Researchers…
…switching off the activity of two key genes – raising the possibility of outsmarting cancer by predicting drug resistance in advance. ‘Click’ chemistry used to tag proteins made by cancer…
…the UK’s largest health research programme and the innovative application of a Nobel prize-winning chemistry technique. You can listen below, or find The Drug Discovery World Podcast on Spotify, Google…
…launch of the UK’s largest health research programme and the innovative application of a Nobel prize-winning chemistry technique. You can listen below, or find The Drug Discovery World Podcast on…
…drug discovery today vs outlook into the future Dr Horan is the Vice President of Medicinal Chemistry at Nuvalent, a biotech company creating precisely targeted therapies for patients with cancer….
…and Epstein-Barr virus, as well as the launch of the UK’s largest health research programme and the innovative application of a Nobel prize-winning chemistry technique. This week’s top stories: Could…
…cells make these proteins, they remain marked with the chemical tag, meaning that researchers can identify them. ‘Click’ chemistry The method uses bioorthogonal or ‘click’ chemistry, which was awarded this…
…clinical development in 2024. The company will also broaden its drug discovery and development platforms, including an RNA chemistry platform and an exploratory platform to expand research into a wider…
…of Andreas Schoop, PhD, Head of Medicinal Chemistry, WuXi AppTec HitS & Moran Jerabek-Willemsen, PhD, Head of Biophysics & Screening, WuXi AppTec HitS. To secure your place, register for FREE…
…inappropriate due to intolerance or contraindications or in addition to other medicinal products. It is the first GIP and GLP-1 receptor agonist authorised for the treatment of adults with type…
…been granted Fast Track and Orphan Drug designations by the US Food and Drug Administration (FDA) and PRIority MEdicines (PRIME), Advanced Therapy Medicinal Product (ATMP) and Orphan designations by the…
…compounds (400-600 g/mol) generally requires libraries of millions of compounds. The webinar features the expertise of Andreas Schoop, PhD, Head of Medicinal Chemistry, WuXi AppTec HitS & Moran Jerabek-Willemsen, PhD,…
Biosynth are experts in complex chemistry, peptides and key biological raw materials, providing more than half a million research products plus end-to-end manufacturing including discovery, optimisation, and scale up. Biosynth…
